- Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform
May 14, 2026 · prnewswire.com
First Commercial Installation Targeted for July 2026 in San Antonio; Strategic Reference Site Positions Velocity Bioworks at the Forefront of Next-Generation NMR-Based Diagnostics SAN ANTONIO, May 14, 2026 /PRNewswire/ -- Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) (Nasdaq: VBIO), a clinical-stage immunotherapeutics company, today announced that its wholly owned subsidiary, Velocity Bioworks, has entered into an exclusive commercial development and license agreement with LarmorBio, Inc. ("LarmorBio") for LarmorBio's BioScan-NMR™ platform, a next-generation nuclear magnetic resonance (NMR) system. Under the agreement, Velocity Bioworks will host the first commercial deployment of the BioScan-NMR platform, with installation and commissioning at the Company's San Antonio facility targeted for July 2026.
- VALION BIO'S VELOCITY BIOWORKS SECURES EXCLUSIVE COMMERCIAL LICENSE TO LARMORBIO'S BIOSCAN-NMR™ PLATFORM
May 14, 2026
FIRST COMMERCIAL INSTALLATION TARGETED FOR JULY 2026 IN SAN ANTONIO; STRATEGIC REFERENCE SITE POSITIONS VELOCITY BIOWORKS AT THE FOREFRONT OF NEXT-GENERATION NMR-BASED DIAGNOSTICS SAN ANTONIO, MAY 14, 2026 /PRNEWSWIRE/ -- VALION BIO, INC. (FORMERLY TIVIC HEALTH SYSTEMS, INC.) (NASDAQ: VBIO), A CLINICAL-STAGE IMMUNOTHERAPEUTICS COMPANY, TODAY ANNOUNCED THAT ITS WHOLLY OWNED SUBSIDIARY, VELOCITY BIOWORKS, HAS ENTERED INTO AN EXCLUSIVE COMMERCIAL DEVELOPMENT AND LICENSE AGREEMENT WITH LARMORBIO, INC. ("LARMORBIO") FOR LARMORBIO'S BIOSCAN-NMR™ PLATFORM, A NEXT-GENERATION NUCLEAR MAGNETIC RESONANCE (NMR) SYSTEM. UNDER THE AGREEMENT, VELOCITY BIOWORKS WILL HOST THE FIRST COMMERCIAL DEPLOYMENT OF THE BIOSCAN-NMR PLATFORM, WITH INSTALLATION AND COMMISSIONING AT THE COMPANY'S SAN ANTONIO FACILITY TARGETED FOR JULY 2026.
- NMR or HOOD: Which Is the Better Value Stock Right Now?
May 14, 2026 · zacks.com
Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and Robinhood Markets, Inc. (HOOD). But which of these two companies is the best option for those looking for undervalued stocks?
- Should Value Investors Buy Nomura (NMR) Stock?
May 14, 2026 · zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Nomura Asset Management Appoints Chief Investment Strategist
Apr 30, 2026 · businesswire.com
PHILADELPHIA--(BUSINESS WIRE)--Nomura Asset Management today announced the appointment of Andrew “Andy” Goldberg as Chief Investment Strategist of Nomura Asset Management International1, a newly created role designed to elevate the firm's global thought leadership position and accelerate growth across our institutional and wealth channels. Andy will be responsible for developing and commercializing investment insights across the platform, positioning the firm as a leading voice on markets and i.
- NOMURA ASSET MANAGEMENT APPOINTS CHIEF INVESTMENT STRATEGIST
Apr 30, 2026
PHILADELPHIA--(BUSINESS WIRE)--NOMURA ASSET MANAGEMENT TODAY ANNOUNCED THE APPOINTMENT OF ANDREW “ANDY” GOLDBERG AS CHIEF INVESTMENT STRATEGIST OF NOMURA ASSET MANAGEMENT INTERNATIONAL1, A NEWLY CREATED ROLE DESIGNED TO ELEVATE THE FIRM'S GLOBAL THOUGHT LEADERSHIP POSITION AND ACCELERATE GROWTH ACROSS OUR INSTITUTIONAL AND WEALTH CHANNELS. ANDY WILL BE RESPONSIBLE FOR DEVELOPING AND COMMERCIALIZING INVESTMENT INSIGHTS ACROSS THE PLATFORM, POSITIONING THE FIRM AS A LEADING VOICE ON MARKETS AND I.
- NMR vs. HOOD: Which Stock Is the Better Value Option?
Apr 28, 2026 · zacks.com
Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and Robinhood Markets, Inc. (HOOD). But which of these two stocks is more attractive to value investors?
- Are Investors Undervaluing Nomura (NMR) Right Now?
Apr 28, 2026 · zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Nomura: IB Could Recover In Ebullient Q1, Macquarie Integration Costs Will Pass
Apr 26, 2026 · seekingalpha.com
Nomura trades at a notable discount (11x PE) versus global peers, despite solid performances and temporarily depressed income. Temporary acquisition-related costs from the Macquarie deal will pressure profits through the next year, but underlying asset management inflows and alternative AUM growth remain robust. Wholesale and IB segments benefit from Japanese market dynamics, including PBR-related reform from the TSE for the Japan-facing IB businesses.
- Nomura Holdings, Inc. (NMR) Q4 2026 Earnings Call Transcript
Apr 24, 2026 · seekingalpha.com
Nomura Holdings, Inc. (NMR) Q4 2026 Earnings Call Transcript